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SOCS1 Prevents Potentially Skin-Reactive Cytotoxic
T Lymphocytes from Gaining the Ability to Cause
Inflammatory Lesions
Galaxia Maria Rodriguez1, Dante D’Urbano2, Diwakar Bobbala1, Xi Lin Chen1, Mehdi Yeganeh1,
Sheela Ramanathan1,3 and Subburaj Ilangumaran1,3
Suppressor of cytokine signaling 1 (SOCS1) is a critical regulator of T lymphocyte homeostasis. SOCS1-deficient
mice accumulate CD8þ T cells, which display a memory-like phenotype and proliferate strongly to IL-15. Socs1 /
mice develop inflammatory skin lesions, however, the underlying mechanisms are not well understood. In order
to investigate the role of SOCS1 in regulating CD8þ T cells potentially reactive to tissue antigens (Ags) of the skin,
we generated Socs1 / mice expressing MHC-I–restricted Pmel-1 transgenic TCR specific to the melanoma-
derived gp100 Ag, which is also expressed by normal melanocytes. Socs1 / Pmel-1 cells express increased levels
of memory markers CD44, Ly6C, CD122, and CD62L, and show downregulation of TCR and upregulation of CD5,
suggesting in vivo TCR stimulation. However, stimulation of Socs1 /Pmel-1 cells with gp100-derived peptide
induced only marginal proliferation in vitro despite eliciting strong effector functions, which was associated with
elevated Blimp-1 induction. Following adoptive transfer to Rag1 / mice, Socs1 /Pmel-1 cells underwent
lymphopenia-induced proliferation and caused severe skin pathology characterized by inflammatory lesions in
ears, muzzle, extremities, and eyes. These findings underscore the importance of SOCS1 in regulating potentially
skin-reactive cytotoxic T lymphocytes, which could get activated under conditions that promote Ag-nonspecific,
cytokine-driven proliferation.
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INTRODUCTION
The suppressor of cytokine signaling (SOCS) family proteins
regulate cytokine signaling in a negative feedback manner
(Ilangumaran et al., 2004). SOCS1 deficiency in mice causes
premature death due to uncontrolled IFN-g signaling (Marine
et al., 1999). Socs1 / Ifng / mice survive longer, but
develop chronic inflammation in many organs, including
skin, kidneys, lung, heart, and gut (Metcalf et al., 2002;
Cornish et al., 2003a). Socs1 / mice lacking a critical
component of IFN-g signaling also develop skin lesions,
cataract, and orbital cellulites (Yu et al., 2008). This study
showed that SOCS1 deficiency downmodulated the chemokine
receptor CCR7 in CD4þ T lymphocytes, allowing them to
migrate to peripheral tissues and cause inflammation. However,
mechanisms underlying the initiation of inflammatory skin
lesions in Socs1 / mice have not yet been fully elucidated.
SOCS1 is essential to maintain T lymphocyte homeostasis,
which is critically dependent on IL-7 and IL-15 (Jameson, 2002;
Yoshimura et al., 2012). For survival, naive CD8þ T cells
requires IL-7 as well as self-peptide–MHC-I complexes that
provide basal TCR signaling, whereas memory CD8þ T cells
require IL-15 but not TCR stimulation (Takada and Jameson,
2009). Socs1 / Ifng / mice accumulate CD8þ T cells with
CD44hiCD122hi memory-like phenotype due to increased
IL-15 signaling (Ilangumaran et al., 2003; Cornish et al.,
2003a; Ramanathan et al., 2006). This memory-like
phenotype also occurs in Socs1 /CD8þ T cells expressing
transgenic TCR specific to exogenous antigens (Ag; Cornish
et al., 2003b; Ramanathan et al., 2006, 2010). Socs1 / CD8þ
T cells bearing the male Ag-specific H-Y transgenic TCR, which
shows minimal reactivity toward environmental Ag, also display
a memory-like phenotype (Ramanathan et al., 2006). These
observations allowed us to postulate that SOCS1 deficiency
may enable naive CD8þ T cells to respond to minimally
cross-reactive environmental Ag or self-peptide–MHC-I
complexes. Similar activation of potentially self-reactive CD8þ
T lymphocyte clones in Socs1 / mice bearing a polyclonal
TCR repertoire could initiate and perpetuate the inflammatory
processes, leading to chronic skin lesions.
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To test the above hypothesis, we generated Socs1 / mice
expressing transgenic Pmel-1 TCR. The Pmel-1 TCR is reactive
to the human melanoma Ag gp100 (hgp100), which is
homologous to mouse pmel-17 (mgp100) expressed by
normal melanocytes (Kwon et al., 1995; Overwijk et al.,
1998). The Pmel-1 TCR recognizes amino acids 25–33 of
human and mouse gp100 (gp10025–33) presented by the
MHC-I molecule H-2Db (Zhai et al., 1996; Overwijk et al.,
2003). The Pmel-1 TCR does not cause any pathology in mice,
indicating that the antigenic reactivity of Pmel-1 TCR trans-
genic CD8þ T cells (Pmel-1 cells) is efficiently controlled by
immune tolerance mechanisms (Mueller, 2010).
We have recently shown that combinations of inflammatory
and homeostatic cytokines, for instance IL-15 and IL-21, can
synergistically induce Ag-nonspecific proliferation of naive
CD8þ T cells that is accompanied by increased sensitivity
toward cognate Ag and weak TCR ligands (Gagnon et al.,
2008; Ramanathan et al., 2011). We reasoned that the
inflammatory conditions in Socs1 / Ifng / mice (Metcalf
et al., 2002; Cornish et al., 2003a) and the increased
responsiveness of Socs1 / CD8þ T cells to IL-15 and
IL-21 (Gagnon et al., 2007) would allow Ag-nonspecific
activation of Pmel-1 cells in vivo by endogenous cytokines
and enhance their reactivity toward mgp100 expressed by
normal melanocytes. Our findings indeed support this notion
and demonstrate a critical role for SOCS1 in preventing CD8þ
T cells that possess minimal reactivity toward skin tissue Ag
from gaining autoaggressive potential.
RESULTS
SOCS1-deficient Pmel-1 cells display signs of in vivo Ag
stimulation
Like other TCR transgenic Socs1 / mice (Cornish et al.,
2003b; Ramanathan et al., 2006), Socs1 /Pmel-1 mice
became sick early and died by 6 weeks of age. These mice
showed retarded growth and often developed white spots
around eyes, ears, and in extremities (Figure 1a). In both
control and Socs1 /Pmel-1 mice, most CD8þ T cells
expressed the Vb13-containing transgenic TCR (Figure 1b).
Socs1 /Pmel-1 cells showed increased expression of CD44,
CD122, and Ly6C (Figure 1c), a phenotype similar to memory-
like cells arising from lymphopenia-induced proliferation (LIP;
Jameson, 2002). Interestingly, these cells showed elevated
levels of CD5 (Figure 1d), a negative regulator of TCR
signaling that is downmodulated by cytokine stimulation
(Soldevila et al., 2011). Freshly isolated Socs1 /Pmel-1
cells also showed a discernible decrease in TCR expression
(Figure 1d), suggesting prior TCR stimulation (Valitutti et al.,
1996). However, upregulation of CD69 or downmodulation of
CD62L, the hallmarks of acute TCR stimulation, was not
evident in Socs1 /Pmel-1 cells (Figure 1e). Accordingly,
stimulation of purified Pmel-1 cells via TCR cross-linking
showed marginal or negligible decrease in protein tyrosine
phosphorylation, activation of the key signaling protein LAT,
or induction of calcium flux response in SOCS1-deficient cells
compared with control cells (Supplementary Figure S1 online).
These results indicate that Socs1 / Pmel-1 cells not only
display cytokine-induced upregulation of memory cell
markers, but also show altered expression of cell surface
molecules that are modulated by TCR activation without
displaying acute changes of TCR stimulation.
Ag-induced proliferation is impaired in SOCS1-deficient
Pmel-1 cells
We have shown previously that exposure to inflammatory and
homeostatic cytokines enhances Ag responsiveness of naive
CD8þ T cells (Gagnon et al., 2008; Ramanathan et al., 2011).
To determine whether the pathological lesions and premature
death of Socs1 /Pmel-1 mice resulted from increased
Ag responsiveness of Pmel-1 cells to endogenous melano-
cyte gp100, we stimulated lymph node cells from control and
Socs1 /Pmel-1 mice with mgp10025–33 peptide. We
observed that SOCS1-deficient cells proliferated poorly
(Figure 2a, left panel), which was not due to impaired
Ag presentation as purified Socs1 /Pmel-1 cells stimulated
with the same peptide presented by irradiated wild-type
splenocytes also showed reduced proliferation (Figure 2a,
right panel). In both instances, exogenous IL-2 reversed the
defective Ag-induced proliferation of Socs1 /Pmel-1 cells
(Figure 2a). Previous reports have shown that Pmel-1 cells
respond more strongly to hgp10025–33 (KVPRNQDWL) than to
mgp10025–33 (EGSRNQDWL), as the former binds H-2D
b with
greater affinity (Overwijk et al., 1998). Proliferation induced
by hgp10025–33 was also impaired in Socs1
 /Pmel-1 cells,
which was reversed by IL-2 (Figure 2b). Furthermore,
Socs1 /Pmel-1 cells responded poorly to immobilized
anti-CD3/anti-CD28 antibodies (Figure 2c, left panel).
Nonetheless, Socs1 /Pmel-1 cells proliferated robustly to
IL-15 or IL-15 plus IL-21 (Figure 2c, right panel).
TCR reactivity toward MHC–self-peptide complexes
may underlie the defective Ag-induced proliferation of
Socs1 / CD8þ T cells
We have previously shown that Socs1 / CD8þ T cells
expressing the P14 transgenic TCR, specific to a viral Ag, also
displayed impaired Ag-induced proliferation (Ramanathan
et al., 2010). As exposure to inflammatory cytokines increa-
ses Ag responsiveness of naive CD8þ T cells (Gagnon et al.,
2008, 2010), it seems paradoxical that Socs1 /Pmel-1 and
Socs1 /P14 cells, which are likely to have been exposed to
abundant inflammatory cytokines in vivo, show impaired
Ag-induced proliferation. Ag-stimulated CD8þ T cells can
become transiently refractory to TCR stimulation due to
‘‘Ag-induced non-responsiveness’’ (Mescher et al., 2006).
Hence, it is possible that the decreased Ag responsiveness of
Socs1 / CD8þ T cells may be a consequence of increased
Ag responsiveness resulting from persistent exposure to
cognate self (mgp100) or cross-reactive environmental
Ag. Alternately, Socs1 / CD8þ T cells may respond
strongly to self-peptide–MHC-I complexes needed for naive
T cell survival (Jameson, 2002), leading to refractoriness
toward subsequent TCR stimulation. To investigate these
possibilities, we examined Ag responsiveness of Socs1 /
H-Y TCR transgenic CD8þ T cells reactive to the male-
specific H-Y Ag (Ramanathan et al., 2006). The H-Y TCR
displays low affinity toward its cognate peptide and shows
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negligible reactivity to environmental Ag. As shown in
Figure 2d, Socs1 /H-Y cells proliferated poorly to the
cognate peptide despite robust proliferation to cytokines.
These results indicate that increased cytokine responsiveness
of Socs1 / CD8þ T cells may augment their functional
avidity toward MHC-I–self-peptide complexes that may
attenuate their proliferation to subsequent Ag stimulation,
irrespective of their TCR affinity toward cognate peptides.
Socs1 /Pmel-1 cells show increased Ag-specific cytolytic activity
CD8þ T cells that develop Ag-induced non-responsiveness
lose their ability to proliferate to Ag because of impaired IL-2
production but retain their effector functions (Mescher et al.,
2006). Therefore, we examined Ag-induced cytotoxic
T lymphocyte (CTL) activity of Socs1 /Pmel-1 cells.
As shown in Figure 3a (upper panel), Socs1 /Pmel-1 cells
stimulated with mgp10025-33, but not unstimulated cells,
efficiently lysed mgp10025–33-loaded EL-4 targets. These cells
did not lyse target cells loaded with a null peptide
(SGPSNTPPEI), which binds to H-2Db (Ramanathan et al.,
2010). Control Pmel-1 cells showed minimal lytic activity
toward mgp10025–33-loaded targets, whereas the same cells
efficiently lysed hgp10025–33-loaded targets (Figure 3a, upper
and lower panels). Socs1 /Pmel-1 cells also showed
increased lytic activity toward hgp10025–33-loaded targets.
These results indicate that SOCS1 deficiency drives Pmel-1
cells into a state of Ag-specific proliferative unresponsiveness
without compromising their effector functions.
Socs1 /Pmel-1 cells become pathogenic following LIP
Intriguingly, Socs1 /Pmel-1 cells stimulated with IL-15 and
IL-21 displayed high cytolytic activity as Ag-stimulated
cells (Figure 3b). As these cells proliferate robustly to
these cytokines (Figure 2c, right panel), we postulated that
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Figure 1. Socs1 /Pmel-1 cells display signs of in vivo antigen stimulation. (a) Appearance of 4-week-old Socs1 /Pmel-1 and Socs1þ /þ Pmel-1 control
mice. (b–e) Pooled brachial, inguinal, cervical, and mesenteric lymph nodes from 3-week-old mice of the indicated genotype from the same litter were stained for
CD4, CD8, TCR Vb13 (b) and the indicated memory cell markers (c) or molecules that are modulated following antigen stimulation (d and e), and evaluated
by flow cytometry. Numbers within quadrants of dot plots indicate the proportion of cells. Numbers within histograms denote mean channel values. Dotted lines
were placed in histograms for visual comparison. Data shown are representative of similar results from more than three mice from different litters. SOCS1,
suppressor of cytokine signaling 1.
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Socs1 /Pmel-1 cells might become pathogenic under lym-
phopenia conditions, when CD8þ T cells undergo cytokine-
driven homeostatic proliferation. To test this hypothesis, we
labeled splenocytes from control or Socs1 /Pmel-1 mice
with 5-(6)carboxyfluorescein diacetate succinimidyl ester
(CFSE), and adoptively transferred these cells into Rag1 /
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Figure 2. Socs1 / CD8þ T cells show impaired antigen (Ag)-induced proliferation. (a) Lymph node cells (left panel) from 2- to 3-week-old Socs1 / and
control Pmel-1 mice were stimulated with mgp10025–33 with or without IL-2. Purified CD8
þ T cells (right panel) were stimulated with mgp10025–33 presented by
irradiated C57BL/6 splenocytes. (b, c) Lymph node cells were stimulated with hgp10025–33 with or without IL-2, anti-CD3e, and anti-CD28 mAb-coated
Dynabeads or cytokines. (d) Lymph node cells from female Socs1 / or control Rag1 /H-Y TCR transgenic mice were stimulated with H-Y peptide or
cytokines. Cell proliferation was evaluated by [3H]-thymidine incorporation after 2 days (for Ag) or 3 days (cytokines) stimulation. Representative data from at least
three independent experiments are shown. c.p.m., counts per minute; SOCS1, suppressor of cytokine signaling 1.
R Galaxia Maria et al.
SOCS1 Controls Melanocyte-Reactive CTLs
2016 Journal of Investigative Dermatology (2013), Volume 133
recipients. More than 98% of CD8þ T cells recovered from
the recipients of either control or Socs1 /Pmel-1 cells
expressed the transgenic TCR (Figure 4a). Socs1 / CD8þ
T cells underwent pronounced LIP in Rag1 / mice within
5 days after cell transfer, whereas Pmel-1 cells from wild-type
donors underwent limited expansion (Figure 4a). Socs1 /
Pmel-1 cells showed increased expression of CD44 and Ly6C,
whereas CD62L and CD69 levels were comparable between
Socs1
 /
and control cells (Figure 4b). Furthermore, both
control and Socs1 / Pmel-1 cells underwent limited expan-
sion in Rag1 / Il15 / mice, confirming the requirement of
IL-15 for homeostatic expansion (Figure 4c). However,
Socs1 /Pmel-1 cells expanded in Rag1 / Il15 / recipi-
ents contained a pool of rapidly proliferating CFSElo cells,
which may arise from TCR stimulation (Kieper et al., 2005).
Rag1 / recipients that received Socs1 /Pmel-1 cells
developed severe inflammatory skin lesions 2 months after
cell transfer, whereas wild-type Pmel-1 cells failed to cause
disease (Figure 5a). Somewhat unexpectedly, Rag1 / Il15 /
recipients harboring Socs1 /Pmel-1 cells also developed
lesions, albeit with a delay (Figure 5a). Rag1 / recipients
harboring Socs1 / Pmel-1 cells developed lesions in areas
accessible to scratching, particularly in flanks, ears,
muzzle, and eyes (Figure 5b A, B; Supplementary Figure S2
online: i, v). Histology of the affected muzzle skin showed
moderate-to-severe lymphocytic infiltration of dermis and hair
follicles (Figure 5b, C, D vs. E). Cross-section of ear lobes
from Rag1 / mice harboring Socs1 /Pmel-1 cells showed
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with similar results are shown. SOCS1, suppressor of cytokine signaling 1.
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acanthosis, infiltration of lymphocytes and melanophages,
basal cell vacuolization, and reactive keratinocyte atypia,
resembling lichenoid-type interface dermatitis (Supple-
mentary Figure S2 online: ii, iii vs. iv). Some very sick mice
developed cataract and showed lymphocytic infiltration of
peri-orbital and sub-conjunctival tissues, with melanophages
arising from the underlying choroid (Supplementary Figure S2
online: vi, vii). These observations show that reversal of
the Ag-specific proliferative defect by lymphopenia-driven
expansion allows Socs1 /Pmel-1 cells to unleash their
effector functions and cause autoimmune tissue destruction.
Ag stimulation strongly induces Blimp-1 in Socs1 /Pmel-1
cells
To gain insight into the ability of Socs1 /Pmel-1 cells to
cause skin lesion in Rag1 / recipients, we phenotyped the
adoptively transferred Pmel-1 cells at 6 weeks after transfer.
Both wild-type and Socs1 /Pmel-1 cells undergoing LIP
have upregulated CD44, Ly6C, and CD127 to the same
extent, whereas the expression of CD25, CD132, and CCR7
showed negligible changes (Figure 6a). These cells have also
upregulated CD5 and KLRG-1, which are modulated by
cytokine and Ag stimulation (Parish and Kaech, 2009;
Soldevila et al., 2011). A subset of these cells
downregulated CD62L (Figure 6a), suggesting TCR stimulation
in vivo. Overall, there was no appreciable phenotypic
difference between Socs1 / and control Pmel-1 cells recov-
ered from Rag1 / mice 2 months after adoptive transfer.
Recent studies have shown that Blimp-1, a transcriptional
repressor induced by Ag stimulation, favors differentiation of
effector CD8þ T cells during viral infections (Rutishauser
et al., 2009; Welsh, 2009; Crotty et al., 2010). We observed
that Ag stimulation markedly upregulated Blimp-1 in Socs1 /
Pmel-1 cells compared with control cells (Figure 6b).
Ag-stimulated SOCS1-deficient cells also expressed Bcl-6,
which is implicated in promoting cell proliferation (Crotty
et al., 2010). IL-15 and IL-21, which induced strong
proliferation of Socs1 /Pmel-1 cells, did not upregulate
Blimp-1, whereas IL-21–mediated induction of Bcl-6 was
comparable in Socs1 / and control Pmel-1 cells
(Figure 6b). Besides, IL-15 inhibited IL-21–induced Bcl-6 in
both Socs1 / and control Pmel-1 cells. These results suggest
that cytokine-driven proliferation, increased Ag sensitivity, and
Ag-induced upregulation of Blimp-1 may collectively contribute
to the autoaggressive potential of Socs1 /Pmel-1 cells.
DISCUSSION
In this study, we have shown that SOCS1 has a crucial role in
preventing the activation of potentially skin-reactive CD8þ
T cells. Socs1 /Pmel-1 cells undergo robust cytokine-induced
proliferation but proliferate poorly to gp100. This Ag-specific
proliferative unresponsiveness of Socs1 /Pmel-1 cells pre-
sumably develops as a consequence of constant TCR stimula-
tion by endogenous gp100 expressed by normal melanocytes.
Nonetheless, Socs1 /Pmel-1 cells display strong Ag-specific
effector functions, which enables these cells to cause severe
skin lesions under lymphopenic conditions that favor
cytokine-driven homeostatic expansion. Our findings also
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Figure 5. Socs1 /Pmel-1 cells cause severe skin lesions following lymphopenia-induced proliferation. (a) Lymph node cells containing 5 106 CD8þ T cells
from Socs1 / or control Pmel-1 mice were adoptively transferred to Rag1 / or Rag1 / Il15 / recipients and monitored for pathological manifestations.
(b) (A) Representative Rag1 / mice that received Socs1 / (knockout (KO)) or control (wild type (WT)) Pmel-1 cells at 8 weeks after cell transfer.
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implicate SOCS1 in regulating the Blimp-1, an important
regulator of CD8þ T-cell differentiation.
Pmel-1 cells are widely used to study antitumor CTL
responses in the murine B16-F10 melanoma model
(Finkelstein et al., 2004). Pmel-1 cells expanded in vitro
using hgp10025–33 and adoptively transferred to C57Bl/6
mice induce regression of subcutaneously implanted mela-
noma. However, such tumor regression can be achieved only
upon re-stimulation of the donor cells in vivo with hgp10025–33
along with innate immune stimuli (Overwijk et al., 2003;
Finkelstein et al., 2004; Salem et al., 2009). The latter induce
inflammatory cytokines, including those that promote
Ag responsiveness of CD8þ T cells (Mattei et al., 2001;
Kolumam et al., 2005; Salem et al., 2006). In fact, IL-15 and
IL-21 have been shown to facilitate efficient activation of
Pmel-1 cells and enhance their antitumor functions (Klebanoff
et al., 2004; Zeng et al., 2005; Hinrichs et al., 2008). Effective
antitumor response against B16-F10 melanoma is often
accompanied by vitiligo, indicating that normal melanocytes
become targets of cytokine-stimulated, Ag-activated Pmel-1
cells. Our findings show that SOCS1 deficiency enables
Pmel-1 cells to acquire the capacity to attack normal cells
even without exogenous Ag stimulation, and at physiological
levels of cytokines available during lymphopenia. These
observations highlight the key role played by SOCS1 in
preventing potentially autoreactive CD8þ T-cell clones
from gaining the capacity to become auto-aggressive CTLs,
leading to initiation and perpetuation of autoimmune tissue
destruction.
Development of inflammatory lesions in multiple organs of
SOCS1-deficient mice has been variously attributed to hyper-
activation of NKT cells, macrophages, and dendritic cells, and
deregulation of Th1, Th17, and T regulatory cells (Yoshimura
et al., 2012). Even though all these inflammatory cells would
contribute to the chronic inflammatory lesions observed in
SOCS1 null mice, it is also possible that inflammatory
cytokines could facilitate activation of potentially self-
reactive T cells (Ramanathan et al., 2009). Chong et al.
(2005) have shown that SOCS1 deficiency in T cells alone is
not sufficient to induce inflammatory manifestations, which
occurred only upon simultaneous deletion of SOCS1 in
myeloid cells. This study postulated that increased sensitivity
of Socs1 / macrophages to inflammatory stimuli and
abnormally high responsiveness of Socs1 / T cells to pro-
inflammatory cytokines could establish a self-perpetuating,
Ag-nonspecific inflammatory loop between these cells. CD8þ
T cells are the most affected leukocyte population in Socs1 /
mice, characterized by CD44hi-activated/memory phenotype,
which occurs even in the absence of IFN-g (Ilangumaran et al.,
2003; Cornish et al., 2003b). We have shown that this pheno-
typic conversion is driven by IL-15, and SOCS1 attenuates
Ag-nonspecific activation of CD8þ T cells by IL-15 and IL-21
(Ramanathan et al., 2006; Gagnon et al., 2007). Socs1 /
T cells produce IFN-g in response to lipopolysaccharide, IL-1,
tumor necrosis factor-a, IL-2, and IL-15 (Chong et al., 2005;
Ramanathan et al., 2010). Even though IFN-g hastens
inflammation, leading to overt disease in Socs1 / mice at
a very young age, development of inflammatory lesions in
older Socs1 / Ifng / mice indicates that IFN-g is dispen-
sable to initiate and perpetuate the inflammatory loop in
SOCS1-deficient mice. Our findings show that Socs1 /
Pmel-1 cells display potent Ag-specific cytolytic activity
following cytokine or Ag stimulation, which indicate that
increased CTL activity could be a key factor contributing to
the development of autoimmune manifestations in Socs1 /
mice. This notion is also supported by the destruction of
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Figure 6. Socs1 /Pmel-1 cells show increased Blimp-1 expression after
antigen stimulation. (a) Socs1 / and control Pmel-1 cells recovered 6 weeks
after transfer to Rag1 / recipients were evaluated for the indicated cell surface
markers. Freshly isolated control Pmel-1 cells were included for comparison.
(b) Freshly isolated Socs1 / and control Pmel-1 cells were stimulated with
antigen or the indicated cytokines. After 48 hours, cell lystaes were analyzed by
western blot to evaluate Blimp-1 expression. Actin was used to ensure
equivalent protein loading. Data shown are representative of two independent
experiments with similar results. SOCS1, suppressor of cytokine signaling 1.
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pancreatic islets by Socs1 / CD8þ T cells in TCR transgenic
mouse models of autoimmune diabetes (Davey et al., 2005;
Ramanathan et al., 2011).
Even though Socs1 / Pmel-1 cells mount efficient
Ag-specific CTL activity, they display reduced Ag-induced
proliferation, as we have previously reported for P14 cells
(Ramanathan et al., 2010). In our previous study on
Socs1 /P14 cells, we have argued that the Ag-specific
proliferative unresponsiveness of Socs1 / CD8þ T cells is
not related to ‘‘split anergy’’ (Schwartz, 2003) or to Ag-
induced non-responsiveness (Tham et al., 2002) on the
grounds that Socs1 / CD8þ T cells express normal levels
of costimulatory receptors and their proliferative defect cannot
be reversed even after cytokine-driven expansion
(Ramanathan et al., 2010). Our findings indicate that the Ag-
specific proliferative defect in Socs1 / Pmel-1 cells, without
the loss of effector functions, could be related to the increased
level of Blimp-1 expression. It has been shown that Blimp-1 is
upregulated in terminally differentiated CD8þ T effector cells,
whereas central memory cells downmodulate Blimp-1
(Rutishauser et al., 2009). Accordingly, Blimp-1 deficiency
leads to the generation of memory CD8þ T cell subsets with
increased proliferative capacity, whereas overexpression of
Blimp-1 in P14 cells attenuated Ag-induced proliferation
(Rutishauser et al., 2009). Further investigation will reveal
how SOCS1 regulates Ag-induced Blimp-1 expression, and
whether SOCS1 deficiency also modulates the signaling
pathways (NFAT, mTOR, AMPK, DGKa) and expression of
genes (Cbl-b, GRAIL, Otubain1, Ikaros, Egr2/3, CREM)
implicated in the induction and/or maintenance of the
anergic state (Wells, 2009; Chappert and Schwartz, 2010).
Autoreactive T cells that escape negative selection in thymus
are regulated by peripheral tolerance mechanisms, which
include ‘‘ignorance’’ due to tissue-restricted expression of
autoantigens, induction of tolerogenic Ag-presenting cells
and regulatory T cells, and clonal anergy and deletion of
autoreactive cells (Mueller, 2010). Inflammatory conditions
can breach these safety mechanisms by enhancing the
immunogenic properties of Ag-presenting cells. For instance,
in transgenic mice expressing ovalbumin-derived peptide in
skin, adoptive transfer of ovalubumin-specific OT-I TCR
transgenic CD8þ T cells did not cause immunopathology
unless physical skin inflammation was also induced (Bianchi
et al., 2009). Infectious agents can also breach tolerance
mechanisms by providing inflammatory stimuli (Enouz et al.,
2012). Collectively, these studies suggest that autoreative
CD8þ T cells with low-avidity TCR can be activated under
inflammatory conditions. Therefore, the inflammatory status of
Socs1 / mice might have facilitated activation of Pmel-1
cells, however, breakdown of peripheral tolerance and
development of tissue damage required a lymphopenic setting.
Lymphopenia and infections are implicated as important
triggers of autoimmunity (von Herrath et al., 2003; Krupica
et al., 2006; Le Saout et al., 2008; Zhang and Bevan, 2012).
Viral infections are often associated with innate immune
stimulation and transient lymphopenia (von Herrath et al.,
2003; Khoruts and Fraser, 2005). In fact, lymphopenia and
inflammation may collude to trigger autoimmunity. We have
shown that homeostatic cytokines synergize with inflam-
matory cytokines to stimulate Ag-nonspecific proliferation of
naive CD8þ T cells, increase their responsiveness to weak
TCR ligands and elicit their pathogenic potential (Gagnon
et al., 2008, 2010; Ramanathan et al., 2011). SOCS1 is a
critical regulator of this pathogenic mechanism, as previously
shown in an autoimmune diabetes model (Ramanathan et al.,
2010) and by the present study on Pmel-1 cells. Even though
the Socs1 gene has not been directly linked to autoimmunity,
it is epigenetically repressed via promoter methylation and by
microRNA miR155 (Galm et al., 2003; Lu et al., 2009). It will
be worthwhile to investigate the methylation status of Socs1
gene promoter and miR155 expression in clonal populations
of CD8þ T cells in autoimmune disease patients.
MATERIALS AND METHODS
Mice
Socs1þ / Ifng / , Rag1 / Il15 / , Rag1 /H-Ytg and Socs1 /
Rag1 /H-Ytg mice in C57BL/6 background had been previously
described (Marine et al., 1999; Ramanathan et al., 2006, 2010).
Rag1 / mice in C57BL/6 background and Pmel-1 TCR transgenic
mice (Overwijk et al., 2003) were purchased from the Jackson
Laboratory (Bar Harbor, ME). Socs1 /Pmel-1 mice were generated
in our animal facility. The Universite´ de Sherbrooke Ethics Committee
on Care and Use of Animals has approved all experiments using mice.
Reagents
Fluorochrome-conjugated antibodies against mouse cell surface
molecules TCR vb13 (recognizes the Pmel-1 TCR) were from BD
Pharmingen Biosciences (Palo Alto, CA) or eBiosciences (San Diego,
CA). Recombinant IL-2, IL-7, IL-15, and IL-21 were from R&D
Systems (Minneapolis, MN). CFSE and the calcium indicator dye
Fluo-4 were from Molecular Probes (Eugene, OR). Antigenic peptides
were custom synthesized to 495% purity by GenScript (Scotch
Plains, NJ). Antibodies for western blot were purchased from Cell
Signaling Technology (Beverly, MA) or Santa Cruz Biotechnology
(Santa Cruz, CA).
Flow cytometry and cell sorting
Cell staining, flow cytometry data acquisition, and analysis were
carried out as described elsewhere (Gagnon et al., 2008). CD8þ
T cells were purified using Dynal mouse CD8 negative isolation kit
(Life Technologies, Burlington, Canada; Ramanathan et al., 2010).
Cell proliferation
Cell proliferation was measured as detailed previously (Gagnon et al.,
2008). Briefly, total lymph node cells (1 105 cells per well) or
purified CD8þ T cells (2.5 104 cells per well) were stimulated in
96-well culture plates with cytokines, Dynabeads Mouse T-activator
CD3/CD28 (Life Technologies), or antigenic peptides. Irradiated wild-
type splenocytes (105 cells per well) were used as Ag-presenting cells
to stimulate purified cells with Ag. One mCi of methyl-[3H]-thymidine
(NEN Life Sciences, Boston, MA) was added during the last 8 hours of
culture and radioactivity incorporation was measured. Statistical
significance was calculated by Student’s t-test.
In vivo proliferation
Splenocytes labeled with CFSE were injected into 6- to 8-week-old
Rag1 / or Rag1 / Il15 / mice (10 106 cells in 200ml
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phosphate-buffered saline) and analyzed as described elsewhere
(Ramanathan et al., 2006).
TCR signaling and calcium response
Purified 1 106 CD8þ T cells were incubated with anti-CD3 mAb
2C11 in cold for 15 minutes, washed, thawed to 37 1C, and exposed
to goat anti-hamster IgG (Jackson Laboratory) to cross-link the CD3–
TCR complex. At indicated time points, cells were lysed in SDS-PAGE
sample buffer and analyzed by western blot as described previously
(Gagnon et al., 2010). To measure TCR-induced calcium flux,
purified CD8þ T cells, loaded with the calcium indicator dye
Fluo-4, were stimulated using 2C11 Ab followed by its cross-
linking. Ca2þ flux was recorded by flow cytometry as detailed
elsewhere (Ilangumaran et al., 2009).
CTL assay
Target EL-4 cells, prepared by incubation with 400mCi ml 1 of 51Cr
(NEN Life Sciences) and peptides for 2 hours at 37 1C, were washed
and cultured with activated Pmel-1 cells at different effector to target
cell ratios. After 7 hours at 37 1C, released radioactivity was measured
and specific lysis was calculated as previously described (Gagnon
et al., 2008).
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